News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Andrés Gómez De León, MD

Articles by Andrés Gómez De León, MD

Tandem 2022 Presentation: Haploidentical versus Matched Unrelated Donor Transplants for Lymphomas Using Post-transplant Cyclophosphamide

Tandem 2022 Presentation: Haploidentical versus Matched Unrelated Donor Transplants for Lymphomas Using Post-transplant Cyclophosphamide

ByAndrés Gómez De León, MD

October 13th 2022

This article was written for and by CancerNetwork partner, the American Society for Transplantation and Cellular Therapy.

Outcomes of Patients on Transplant Waiting Lists: Q&A with Dr. Giancarlo Fatobene

Outcomes of Patients on Transplant Waiting Lists: Q&A with Dr. Giancarlo Fatobene

ByGiancarlo Fatobene, MD,Andrés Gómez De León, MD

June 16th 2022

The following was recently published in ASTCT’s Nucleus publication. Follow @ATSTCT for the latest on all-things cellular therapy.

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)